The SocietyMore than 35,000 clinicians, scientists and allied health professionals from over 160 countries are part of the ERS communityBecome an ERS member
A week-long virtual event dedicated to postgraduate courses, where medical practitioners will have the opportunity to align their current procedures with the latest clinical best practice.
These lecture-based sessions include dedicated time for interaction between participants and faculty. Participants will put knowledge into practice by taking part in group tasks led by top level faculty.
An application will be submitted to EBAP (European Board for Accreditation in Pneumology) for CME accreditation of this event. The number of credits that you will receive will correspond to the time you spend viewing the sessions live.
Please note that all timings are in Central European Summer Time (CEST). Recordings of each session will be made available to registered participants after the event.
The programme will consist of the following postgraduate courses:
|PG1 Sleep disordered breathing in obstructive and restrictive lung diseases: from pathophysiology to treatment |
Aims: To describe hypoventilation syndromes and sleep disordered breathing in relation to different chronic respiratory diseases; to differentiate, diagnose and manage hypoventilation and sleep disordered breathing in patients with chronic respiratory diseases; to describe the pathophysiology, clinical features and consequences of chronic respiratory diseases and to differentiate among their comorbidities.
|PG2 Drug-resistant tuberculosis|
Aims: To present a number of tuberculosis (TB) patients with common and difficult issues; to present an update on the current management of multidrug-resistant TB (MDR-TB); to determine the best clinical approaches and management by applying current evidence and guidelines; and to describe diagnostic tests and their interpretation, the design of treatment regimens, including drugs and their side effects and the impact of co-morbidities, by presenting challenging cases of drug-resistant TB.
|PG3 Masterclass updates in asthma and COPD|
Aims: To describe methods of diagnosing and managing patients with difficult-to-treat asthma; to present methods of assessing and treating patients with severe asthma phenotypes and of monitoring the effects of treatment of severe asthma based on recent updates; to describe methods of assessing COPD that can determine the severity of airflow limitation and the risk of exacerbations; to identify the main goals of COPD assessment that include determinations of the presence and severity of spirometric abnormalities, the magnitude of patient symptoms, the history of exacerbations and future risks, and the presence of comorbidities; to describe the ability of pharmacologic therapy to reduce COPD symptoms and the frequency and severity of exacerbations; and to describe the importance of individualising pharmacologic treatments based on the severity of symptoms, the risk of exacerbations, side-effects and comorbidities, patient preference, and patient ability to use drug delivery devices.
|PG4 Back to clinical physiology|
Aims: To understand the basic principles of respiratory physiology and how and to what extent they apply to clinical practice.
|PG5 Pleural disease: integrating 2021 evidence with real life cases|
Aims: To present all aspects of pleural disease, including 1) the pathophysiology of effusion formation and symptoms; 2) the optimal diagnostic methods, including emerging data on rationalisation steps and direct-to-biopsy strategies; 3) a synthesis of high-quality evidence that enables management of patients with malignant pleural effusion; 4) the evolving oncological management of mesothelioma; 5) pleural infection: from bench-to-bedside; and 6) a review of the optimal management of pneumothorax, including the results of soon to be published phase III trials of ambulatory/conservative strategies.
|PG6 Noninvasive monitoring in the Respiratory Intensive Care Unit|
Aims: To provide an update on methods for noninvasively monitoring respiratory critical care patients; and to encourage the implementation/improvement of noninvasive procedures to assess and monitor patients’ respiratory conditions in the intensive care unit (ICU), including the early identification of responders to noninvasive and invasive respiratory support and/or medical therapy.
|PG7 Emerging infectious diseases and antimicrobial resistance: diagnostics, treatments, vaccines and other preventive and/or therapeutic interventions |
Aims: To review the current evidence regarding novel or improved microbiological diagnostic tests, new preventive and therapeutic strategies to better respond to ID threats.
|PG8 Advanced cardiopulmonary exercise testing|
Aims: At the end of the course, the participants will understand the physiological constraints of exercise tolerance and its application in clinical practice; appreciate the optimal methods for testing lung mechanics and spirometry; understand the different formats of exercise tests, their advantages and disadvantages, and their different prognostic values in adults and children; and appreciate the usefulness of exercise testing for evaluating pharmacological and non-pharmacological interventions in clinical practice.
|PG9 Acute and chronic cough in children|
Aims: To present guidelines on the treatment of childhood cough; and to describe possible pitfalls and difficult differential diagnoses, as well as important differences between childhood and adult cough.
|PG10 Imaging guided interventional pulmonology |
Aims: To describe the roles of endobronchial ultrasound (EBUS) and virtual bronchoscopy in the preoperative assessment of patients undergoing endoscopic treatment for emphysema; and to determine the ability of imaging to enhance limited surgical interventions.
|PG11 Pulmonary hypertension in a nutshell|
Aims: This session will provide participants with an understanding of the physiology of the right ventricle and pulmonary hemodynamics and health and disease, explore how to make a correct diagnosis in pulmonary hypertension including pitfalls, discuss how to interpret a right heart catheterisation, explain the principles of treatment in PAH and CTEPH, and describe how to organise PAH/CTEPH care in your region/country.
Access the virtual programme
|Postgraduate course||ERS member||Non-members|
|Full week of PGs: Access all of the postgraduate courses||€90||€130|
|PG1 Sleep disordered breathing in obstructive and restrictive lung diseases: from pathophysiology to treatment||€60||€90|
|PG2 Drug-resistant tuberculosis||€30||€40|
|PG3 Masterclass updates in asthma and COPD||€30||€40|
|PG4 Back to clinical physiology||€30||€40|
|PG5 Pleural disease: integrating 2021 evidence with real life cases||€60||€90|
|PG6 Noninvasive monitoring in the Respiratory Intensive Care Unit||€30||€40|
|PG7 Emerging infectious diseases and antimicrobial resistance: diagnostics, treatments, vaccines and other preventive and/or therapeutic interventions||Free||Free|
|PG8 Advanced cardiopulmonary exercise testing||€30||€40|
|PG9 Acute and chronic cough in children||€30||€40|
|PG10 Imaging guided interventional pulmonology||€30||€40|
|PG11 Pulmonary hypertension in a nutshell||€30||€40|